Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations.


Journal

Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600

Informations de publication

Date de publication:
09 09 2020
Historique:
received: 20 10 2019
accepted: 08 06 2020
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 27 8 2021
Statut: epublish

Résumé

Pathological forms of TAR DNA-binding protein 43 (TDP-43) are present in motor neurons of almost all amyotrophic lateral sclerosis (ALS) patients, and mutations in TDP-43 are also present in ALS. Loss and gain of TDP-43 functions are implicated in pathogenesis, but the mechanisms are unclear. While the RNA functions of TDP-43 have been widely investigated, its DNA binding roles remain unclear. However, recent studies have implicated a role for TDP-43 in the DNA damage response. We used NSC-34 motor neuron-like cells and primary cortical neurons expressing wildtype TDP-43 or TDP-43 ALS associated mutants (A315T, Q331K), in which DNA damage was induced by etoposide or H We demonstrate that wildtype TDP-43 is recruited to sites of DNA damage where it participates in classical NHEJ DNA repair. However, ALS-associated TDP-43 mutants lose this activity, which induces DNA damage. Furthermore, DNA damage is present in mice displaying TDP-43 pathology, implying an active role in neurodegeneration. Additionally, DNA damage triggers features typical of TDP-43 pathology; cytoplasmic mis-localisation and stress granule formation. Similarly, inhibition of NHEJ induces TDP-43 mis-localisation to the cytoplasm. This study reveals that TDP-43 functions in DNA repair, but loss of this function triggers DNA damage and is associated with key pathological features of ALS.

Sections du résumé

BACKGROUND
Pathological forms of TAR DNA-binding protein 43 (TDP-43) are present in motor neurons of almost all amyotrophic lateral sclerosis (ALS) patients, and mutations in TDP-43 are also present in ALS. Loss and gain of TDP-43 functions are implicated in pathogenesis, but the mechanisms are unclear. While the RNA functions of TDP-43 have been widely investigated, its DNA binding roles remain unclear. However, recent studies have implicated a role for TDP-43 in the DNA damage response.
METHODS
We used NSC-34 motor neuron-like cells and primary cortical neurons expressing wildtype TDP-43 or TDP-43 ALS associated mutants (A315T, Q331K), in which DNA damage was induced by etoposide or H
RESULTS
We demonstrate that wildtype TDP-43 is recruited to sites of DNA damage where it participates in classical NHEJ DNA repair. However, ALS-associated TDP-43 mutants lose this activity, which induces DNA damage. Furthermore, DNA damage is present in mice displaying TDP-43 pathology, implying an active role in neurodegeneration. Additionally, DNA damage triggers features typical of TDP-43 pathology; cytoplasmic mis-localisation and stress granule formation. Similarly, inhibition of NHEJ induces TDP-43 mis-localisation to the cytoplasm.
CONCLUSIONS
This study reveals that TDP-43 functions in DNA repair, but loss of this function triggers DNA damage and is associated with key pathological features of ALS.

Identifiants

pubmed: 32907630
doi: 10.1186/s13024-020-00386-4
pii: 10.1186/s13024-020-00386-4
pmc: PMC7488163
doi:

Substances chimiques

DNA-Binding Proteins 0
TARDBP protein, human 0
TDP-43 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

51

Références

DNA Repair (Amst). 2008 Oct 1;7(10):1765-71
pubmed: 18675941
J Mol Biol. 2014 Oct 9;426(20):3376-88
pubmed: 25128619
Semin Neurol. 2007 Feb;27(1):48-57
pubmed: 17226741
Rev Neurosci. 2007;18(2):115-36
pubmed: 17593875
Angew Chem Int Ed Engl. 2008;47(33):6172-6
pubmed: 18646237
J Exp Med. 2011 Nov 21;208(12):2429-47
pubmed: 22084410
Neurotox Res. 2015 Aug;28(2):138-46
pubmed: 26013250
Mol Neurodegener. 2014 Sep 20;9:38
pubmed: 25239657
PLoS Genet. 2008 Jun 27;4(6):e1000110
pubmed: 18584027
Neuron. 2014 Jul 16;83(2):266-282
pubmed: 25033177
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7701-E7709
pubmed: 27849576
J Comp Neurol. 2007 Jan 1;500(1):20-46
pubmed: 17099894
Cell Cycle. 2008 Sep 15;7(18):2902-6
pubmed: 18769152
Mol Cell Neurosci. 2017 Sep;83:46-54
pubmed: 28687523
Acta Neuropathol. 2015 Nov;130(5):643-60
pubmed: 26197969
Mutat Res. 2008 May 10;641(1-2):43-7
pubmed: 18423498
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4696-4705
pubmed: 30770445
Transl Neurodegener. 2017 Jun 16;6:15
pubmed: 28638596
J Biol Chem. 2013 Aug 23;288(34):24731-41
pubmed: 23833192
Prog Biophys Mol Biol. 2015 Mar;117(2-3):194-205
pubmed: 25550082
Neuron. 2013 Aug 7;79(3):416-38
pubmed: 23931993
Curr Alzheimer Res. 2011 May;8(3):273-94
pubmed: 21222600
Hum Mol Genet. 2018 Aug 1;27(15):2658-2670
pubmed: 29750243
Acta Neuropathol Commun. 2015 Jun 25;3:36
pubmed: 26108367
Nat Commun. 2018 Sep 24;9(1):3882
pubmed: 30250272
Am J Hum Genet. 2004 Jun;74(6):1128-35
pubmed: 15106121
J Clin Invest. 2014 Mar;124(3):981-99
pubmed: 24509083
J Neurosci. 2010 May 5;30(18):6171-7
pubmed: 20445041
Science. 2008 Mar 21;319(5870):1668-72
pubmed: 18309045
Neural Regen Res. 2017 Sep;12(9):1441-1442
pubmed: 29089988
Neuron. 2019 Sep 4;103(5):802-819.e11
pubmed: 31272829
J Mol Biol. 2003 Feb 7;326(1):93-103
pubmed: 12547193
Mutat Res. 2011 Jun 3;711(1-2):61-72
pubmed: 21329706
Acta Neuropathol. 2015 Nov;130(5):679-97
pubmed: 26298469
Hum Mol Genet. 2017 Aug 1;26(15):2882-2896
pubmed: 28481984
J Phys Chem Lett. 2015 Feb 5;6(3):374-82
pubmed: 26261950
Bioinformatics. 2014 Aug 15;30(16):2389-90
pubmed: 24771516
Brain Res. 2009 Dec 11;1305:168-82
pubmed: 19815002
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E736-45
pubmed: 23382207
Hum Mol Genet. 2009 Oct 15;18(R2):R156-62
pubmed: 19808791
Cancer Res. 2006 May 15;66(10):5354-62
pubmed: 16707462
J Neurochem. 2009 Nov;111(4):1051-61
pubmed: 19765185
Sci Rep. 2018 May 15;8(1):7551
pubmed: 29765078
In Vivo. 2008 May-Jun;22(3):305-9
pubmed: 18610740
Cell. 2015 Sep 24;163(1):123-33
pubmed: 26406374
Nucleic Acids Res. 2010 Sep;38(17):5706-17
pubmed: 20460465
Acta Neuropathol Commun. 2014 Dec 10;2:172
pubmed: 25492614
PLoS One. 2010 Oct 11;5(10):e13250
pubmed: 20948999
Sci Rep. 2015 Jan 21;5:7924
pubmed: 25603780
Nat Struct Mol Biol. 2011 Jun 12;18(7):822-30
pubmed: 21666678
J Biol Chem. 2010 Jan 1;285(1):608-19
pubmed: 19887443
Nature. 2015 Feb 12;518(7538):254-7
pubmed: 25642960
Nat Commun. 2016 Apr 15;7:11253
pubmed: 27080313
Neural Plast. 2016;2016:3619274
pubmed: 26942017
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7013-7018
pubmed: 28630286
Neuromolecular Med. 2002;2(1):47-60
pubmed: 12230304
Brain Res Bull. 2007 Jun 15;73(1-3):48-54
pubmed: 17499636
Front Cell Neurosci. 2015 Oct 23;9:423
pubmed: 26557057
Mol Cell Biol. 2014 Apr;34(8):1380-8
pubmed: 24469398
Nat Genet. 2016 Sep;48(9):1037-42
pubmed: 27455347
Sci Rep. 2017 Nov 1;7(1):14882
pubmed: 29093506
Nat Neurosci. 2013 Oct;16(10):1383-91
pubmed: 24036913
Nucleic Acids Res. 1998 Jul 1;26(13):3146-53
pubmed: 9628911
Trends Cell Biol. 2014 Feb;24(2):108-17
pubmed: 24094932
Nat Commun. 2018 Jan 23;9(1):335
pubmed: 29362359
Endocr Relat Cancer. 2009 Sep;16(3):845-56
pubmed: 19509065
Cell. 2018 May 3;173(4):958-971.e17
pubmed: 29628143
PLoS One. 2013 Nov 29;8(11):e81170
pubmed: 24312274
Hum Mol Genet. 2019 Apr 01;28(5):2459-2476
pubmed: 31067307
Nucleic Acids Res. 2017 Dec 15;45(22):12862-12876
pubmed: 29140459
Nucleic Acids Res. 2008 Jun;36(11):3847-56
pubmed: 18503084
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Elife. 2019 Mar 20;8:
pubmed: 30893049
Nat Neurosci. 2017 Sep;20(9):1225-1235
pubmed: 28714954
Anticancer Res. 2000 Sep-Oct;20(5A):3189-93
pubmed: 11062742
J Neurochem. 2018 Feb 27;:
pubmed: 29486049

Auteurs

Anna Konopka (A)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Donna R Whelan (DR)

Department of Pharmacy and Biomedical Sciences, La Trobe Institute for Molecular Science, La Trobe University, Bendigo, VIC, Australia.

Md Shafi Jamali (MS)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Emma Perri (E)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Hamideh Shahheydari (H)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Reka P Toth (RP)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Sonam Parakh (S)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Tina Robinson (T)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Bundoora, VIC, Australia.

Alison Cheong (A)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Bundoora, VIC, Australia.

Prachi Mehta (P)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Marta Vidal (M)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Audrey M G Ragagnin (AMG)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Ivan Khizhnyak (I)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Cyril J Jagaraj (CJ)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Jasmin Galper (J)

Brain and Mind Centre, Central Clinical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.

Natalie Grima (N)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Anand Deva (A)

Department of Plastic and Reconstructive Surgery, Macquarie University, and The Integrated Specialist Healthcare Education and Research Foundation, Sydney, Australia.

Sina Shadfar (S)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Garth A Nicholson (GA)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.
ANZAC Research Institute, Concord Hospital, University of Sydney, Sydney, NSW, Australia.

Shu Yang (S)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Suzanne M Cutts (SM)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Bundoora, VIC, Australia.

Zuzana Horejsi (Z)

Barts Cancer Institute, Queen Mary University of London, London, UK.

Toby D M Bell (TDM)

School of Chemistry, Monash University, Wellington Road, Clayton, VIC, Australia.

Adam K Walker (AK)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.
Neurodegeneration Pathobiology Laboratory, Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia.

Ian P Blair (IP)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia.

Julie D Atkin (JD)

Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Macquarie University, 75 Talavera Road NSW, North Ryde, NSW, 2109, Australia. julie.atkin@mq.edu.au.
Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Bundoora, VIC, Australia. julie.atkin@mq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH